Atrial fibrillation, a type of irregular heartbeat, can lead to stroke, blood clots and other complications.

Know your risk to reduce your risk.

Colorectal Cancer

Do you know which factors influence your risk of developing atrial fibrillation?

AF risk factors
Multi Test risk reduction plan with Doctor

Be proactive about your risk of atrial fibrillation

Atrial fibrillation (AF) can increase your risk of developing blood clots, stroke, heart failure and other complications.

Get ahead of the disease. If you know your risk, you can make proactive changes to prevent AF from occurring.

Manage your risk before you develop AF, or any associated diseases.

Is geneType for Atrial Fibrillation right for you?

GeneType for Atrial Fibrillation is appropriate for:

  • Adults 40-85 years old
  • without a previous diagnosis of AF

 

Multi Test risk reduction plan with Doctor

Simple, Actionable Results

GeneType reports help you and your health provider translate your personal clinical, family and genetic data into an actionable preventable health plan.

Key features of the report:

  • Your personal 10-year risk score; this is the chance you develop AF over the next 10 years. Your healthcare provider will use your risk score to tailor risk-reducing recommendations for you. 
  • Recommendations based on the latest AAC/AHA guidelines; your healthcare provider will discuss these recommendations with you. 

 

Sample patient report
AF-USA
The more you know about your risk, the more you can do to try and prevent AF.

Personalized risk score. Personalized health plan. 

Risk reducing options exist for you. 

 

Know your risk of atrial fibrillation so you can take action

Speak to your healthcare provider today about geneType.

To order online through our patient portal, follow these four simple steps to be connected with a third-party telehealth provider.

Step 1

Register for your geneType test using our portal.

Depending on the test, you may require access to your medical records (ex. lipid panel or breast density results). 

Payment will be collected at time of registration.

Step 2

Your clinical information will be reviewed by our 3rd party telehealth partner, DNA Visit.

If you qualify for testing, a kit will be shipped to your address on file.

If you do not qualify for testing, you will receive a refund.

Step 3

Complete saliva sample collection as instructed and return in pre-paid envelope.

Do not eat, drink, smoke, vape or chew gum within 30 minutes of collection. 

Step 4

When your results are ready, you will have the chance to speak with your DNA Visit healthcare provider.

All at-risk patients will be required to speak with the provider prior to results-release.

Order Now

Have questions? We have answers.

If your question is not shown here, please contact us directly.

Is this test reimbursed by insurance?

No. At this time geneType is a self-pay test. However, you may use FSA/HSA to pay for the test.

Does this test cover all the atrial fibrillation risk factors?

It is not possible to incorporate all potential risk factors for atrial fibrillation into a single risk prediction model. However, geneType incorporates the most impactful factors. Test results should be interpreted by a health provider in the context of your clinical and family history.

I bought a different test online and it is showing I had a high polygenic risk of atrial fibrillation, should I retest with geneType?

Yes.

While there are other companies out there that provide random lists of genetic markers that are associated with atrial fibrillation, there are no checks and balances associated with the results they provide. Most of the markers they pull from peer-reviewed publications without cross validating the markers. And more importantly, geneType goes through rigorous statistical validation of the genetic component prior to integrating it into the full model. The fully integrated geneType model is then validated separately.

Are there female-specific risk factors incorporated into this test?

No. Even though AF may present differently in men and women, there are currently no specific risk factors that differ between the two sexes. A woman’s age is incorporated into the model and indirectly accounts for post-menopausal changes associated with increased risk of developing AF. Please make sure you discuss all risk factors with your healthcare providers, including ones that are not in the geneType test.

Multitest V3 2024

*Patient eligibility dependent on personal medical history, age and sex

Interested in ordering more than one disease? Order geneType Multi-Test.

See individual disease pages for more information about each test.

The Multi-Risk suite of tests is for adults 40-85 years of age. At maximum, a woman would be eligible for 8 diseases in the panel; a man would be eligible for 7. Starting at age 30, a patient may qualify for geneType's cancer risk assessments only.

What’s happening?

References

 

  1. Kahwati L, Asher GN, Kadro ZO, et al. Screening for Atrial Fibrillation: An Evidence Review for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2022 Jan. (Evidence Synthesis, No. 208.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK577975/
  2. Arnett DK et al. J Am Coll Cardiol 2019;74(10):1376–414.

Accredited For Compliance With NPAAC Standards And ISO 15189

CLIA Number 99D2023356

Thanks for your Order!

img OK